Minimal Residual Disease–Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Receiving First-Line Therapy
Ashaye A, Chalandon Y, Boissel N, Fazioli K, Wang B, Aldoss I, Huang F, Leonard J, Szabo N, McCloskey C, Nair S, Dalal M, Hennessy M, Yeh T, Martinelli G, Badar T, Kantarjian H, Ribera J, Jabbour E. Minimal Residual Disease–Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Receiving First-Line Therapy. Clinical Lymphoma Myeloma & Leukemia 2024, 24: s161. DOI: 10.1016/s2152-2650(24)00430-0.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply